Literature DB >> 3091241

Intravesical chemotherapy. Studies on the relationship between pH and cytotoxicity.

E Groos, L Walker, J R Masters.   

Abstract

The influence of pH on the antitumor activity of drugs used for intravesical chemotherapy was studied. A human continuous cell line derived from a transitional cell carcinoma of the bladder was exposed to 6 drugs (Adriamycin [doxorubicin], cisplatin, epirubicin, epodyl, mitomycin C, and thiotepa) for 1 hour at 11 pH values ranging from 5.2 to 9.7, and cytotoxicity was measured by inhibition of colony formation. pH had a marked influence on drug activity: cisplatin, mitomycin C, and thiotepa were most cytotoxic in acid media, Adriamycin, and epirubicin in alkaline media, while epodyl was the only drug whose cytotoxicity was unaffected by pH. In addition to these in vitro studies, comparisons were made of the pH of urine samples obtained from patients immediately before and at the completion of intravesical chemotherapy. Changes in pH up to a maximum of +/- 1.6 units were observed, although in most cases, values were similar before and after therapy. All the drugs used were acidic in solution, with the exception of thiotepa. It is concluded that by adjusting solvent and urine pH to the optimum value for each drug, the effectiveness of intravesical chemotherapy might be enhanced.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3091241     DOI: 10.1002/1097-0142(19860915)58:6<1199::aid-cncr2820580604>3.0.co;2-z

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  14 in total

1.  Measurement of urine pH for epidemiological studies on bladder cancer.

Authors:  Juan Alguacil; Ruth M Pfeiffer; Lee E Moore; Manuel Rivas Del Fresno; Rafael Medina-Lopez; Manolis Kogevinas; Roel Vermeulen; Mustafa Dosemeci; Debra T Silverman; Nathaniel Rothman; Montserrat García-Closas
Journal:  Eur J Epidemiol       Date:  2007-03-03       Impact factor: 8.082

Review 2.  Drug resistance and cellular adaptation to tumor acidic pH microenvironment.

Authors:  Jonathan W Wojtkowiak; Daniel Verduzco; Karla J Schramm; Robert J Gillies
Journal:  Mol Pharm       Date:  2011-10-26       Impact factor: 4.939

3.  ThioTEPA pharmacokinetics during intravesical chemotherapy and the influence of Tween 80.

Authors:  J R Masters; B J McDermott; W E Jenkins; E Fenwick; P J Shah; A R Mundy; P M Loadman; M C Bibby
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

4.  Different pH dependency of mitomycin C activity in monolayer and three-dimensional cultures.

Authors:  W C Yen; T Schmittgen; J L Au
Journal:  Pharm Res       Date:  1996-12       Impact factor: 4.200

5.  Use of pharmacologic data and computer simulations to design an efficacy trial of intravesical mitomycin C therapy for superficial bladder cancer.

Authors:  M G Wientjes; R A Badalament; J L Au
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

6.  Intravesical chemotherapy: combination with dimethyl sulfoxide does not enhance cytotoxicity in vitro.

Authors:  L Walker; M C Walker; C N Parris; J R Masters
Journal:  Urol Res       Date:  1988

7.  Effect of pH and moderate hyperthermia on doxorubicin, epirubicin and aclacinomycin A cytotoxicity for Chinese hamster ovary cells.

Authors:  L Kleeberger; E M Röttinger
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

8.  Relative cytotoxicities of adriamycin and epirubicin in combination with lonidamine against human bladder cancer cell lines.

Authors:  R J Popert; J R Masters; M Coptcoat; G Zupi
Journal:  Urol Res       Date:  1995

9.  Sodium bicarbonate nanoparticles modulate the tumor pH and enhance the cellular uptake of doxorubicin.

Authors:  Hanan Abumanhal-Masarweh; Lilach Koren; Assaf Zinger; Zvi Yaari; Nitzan Krinsky; Galoz Kaneti; Nitsan Dahan; Yael Lupu-Haber; Edith Suss-Toby; Esther Weiss-Messer; Michal Schlesinger-Laufer; Janna Shainsky-Roitman; Avi Schroeder
Journal:  J Control Release       Date:  2019-01-05       Impact factor: 9.776

10.  Single early instillation of mitomycin C and urinary alkalinization in low-risk non-muscle-invasive bladder cancer: a preliminary study.

Authors:  Hamit Ersoy; Muhammet Yaytokgil; Ahmet Nihat Karakoyunlu; Hikmet Topaloglu; Levent Sagnak; Hakki Ugur Ozok
Journal:  Drug Des Devel Ther       Date:  2012-12-28       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.